During the past decade, Hopp Children's Cancer Center at NCT Heidelberg (KiTZ) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" #1 collaborator was "Children's Hospital Colorado" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are "Recurrent Adamantinomatous Craniopharyngioma" (2 trials), "Adamantinomatous Craniopharyngioma" (1 trials), "Adamantinous Craniopharyngioma" (1 trials), "Diffuse Intrinsic Pontine Glioma" (1 trials) and "High Grade Glioma" (1 trials). Many other conditions were trialed in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" in a lesser frequency.

Most popular intervention types in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib Oral Tablet [Mektovi]" (1 trials), "Larotrectinib" (1 trials), "Larotrectinib surgical" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".